351 related articles for article (PubMed ID: 17410109)
1. Drug Insight: the use of melatonergic agonists for the treatment of insomnia-focus on ramelteon.
Pandi-Perumal SR; Srinivasan V; Poeggeler B; Hardeland R; Cardinali DP
Nat Clin Pract Neurol; 2007 Apr; 3(4):221-8. PubMed ID: 17410109
[TBL] [Abstract][Full Text] [Related]
2. Ramelteon: a review of its therapeutic potential in sleep disorders.
Pandi-Perumal SR; Srinivasan V; Spence DW; Moscovitch A; Hardeland R; Brown GM; Cardinali DP
Adv Ther; 2009 Jun; 26(6):613-26. PubMed ID: 19568703
[TBL] [Abstract][Full Text] [Related]
3. Ramelteon for the treatment of insomnia.
Borja NL; Daniel KL
Clin Ther; 2006 Oct; 28(10):1540-55. PubMed ID: 17157111
[TBL] [Abstract][Full Text] [Related]
4. Ramelteon: new drug. Insomnia: no role for risky placebos.
Prescrire Int; 2008 Oct; 17(97):183-6. PubMed ID: 19534018
[TBL] [Abstract][Full Text] [Related]
5. Ramelteon: a novel approach in the treatment of insomnia.
Reynoldson JN; Elliott E; Nelson LA
Ann Pharmacother; 2008 Sep; 42(9):1262-71. PubMed ID: 18648020
[TBL] [Abstract][Full Text] [Related]
6. Ramelteon: application withdrawn. Ramelteon in insomnia: withdrawal of marketing application in patients' best interests.
Prescrire Int; 2009 Jun; 18(101):114. PubMed ID: 19639675
[TBL] [Abstract][Full Text] [Related]
7. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
Roth T; Seiden D; Sainati S; Wang-Weigand S; Zhang J; Zee P
Sleep Med; 2006 Jun; 7(4):312-8. PubMed ID: 16709464
[TBL] [Abstract][Full Text] [Related]
8. Tasimelteon, a melatonin agonist for the treatment of insomnia and circadian rhythm sleep disorders.
Hardeland R
Curr Opin Investig Drugs; 2009 Jul; 10(7):691-701. PubMed ID: 19579175
[TBL] [Abstract][Full Text] [Related]
9. Ramelteon: a novel treatment for the treatment of insomnia.
Wurtman R
Expert Rev Neurother; 2006 Jul; 6(7):957-64. PubMed ID: 16831111
[TBL] [Abstract][Full Text] [Related]
10. [A novel therapeutic drug: ramelteon].
Miyamoto M
Nihon Rinsho; 2009 Aug; 67(8):1595-600. PubMed ID: 19768947
[TBL] [Abstract][Full Text] [Related]
11. Ramelteon: a melatonin receptor agonist for the treatment of insomnia.
Devi V; Shankar PK
J Postgrad Med; 2008; 54(1):45-8. PubMed ID: 18296808
[TBL] [Abstract][Full Text] [Related]
12. Jet lag: therapeutic use of melatonin and possible application of melatonin analogs.
Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
Travel Med Infect Dis; 2008; 6(1-2):17-28. PubMed ID: 18342269
[TBL] [Abstract][Full Text] [Related]
13. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty.
Mini LJ; Wang-Weigand S; Zhang J
Am J Geriatr Pharmacother; 2007 Sep; 5(3):177-84. PubMed ID: 17996657
[TBL] [Abstract][Full Text] [Related]
14. Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT1 and MT2 melatonin receptor agonist indicated for treatment of insomnia.
Karim A; Tolbert D; Cao C
J Clin Pharmacol; 2006 Feb; 46(2):140-8. PubMed ID: 16432265
[TBL] [Abstract][Full Text] [Related]
15. The effects of ramelteon in a first-night model of transient insomnia.
Zammit G; Schwartz H; Roth T; Wang-Weigand S; Sainati S; Zhang J
Sleep Med; 2009 Jan; 10(1):55-9. PubMed ID: 18691937
[TBL] [Abstract][Full Text] [Related]
16. Effects of long-term exposure to ramelteon, a melatonin receptor agonist, on endocrine function in adults with chronic insomnia.
Richardson G; Wang-Weigand S
Hum Psychopharmacol; 2009 Mar; 24(2):103-11. PubMed ID: 19090503
[TBL] [Abstract][Full Text] [Related]
17. Acute sleep-promoting action of the melatonin agonist, ramelteon, in the rat.
Fisher SP; Davidson K; Kulla A; Sugden D
J Pineal Res; 2008 Sep; 45(2):125-32. PubMed ID: 18298466
[TBL] [Abstract][Full Text] [Related]
18. Use of a post-sleep questionnaire-interactive voice response system (PSQ-IVRS) to evaluate the subjective sleep effects of ramelteon in adults with chronic insomnia.
Wang-Weigand S; Watissée M; Roth T
Sleep Med; 2011 Oct; 12(9):920-3. PubMed ID: 21925941
[TBL] [Abstract][Full Text] [Related]
19. Melatonergic drugs in clinical practice.
Hardeland R; Poeggeler B; Srinivasan V; Trakht I; Pandi-Perumal SR; Cardinali DP
Arzneimittelforschung; 2008; 58(1):1-10. PubMed ID: 18368944
[TBL] [Abstract][Full Text] [Related]
20. Melatonin and melatonergic drugs on sleep: possible mechanisms of action.
Srinivasan V; Pandi-Perumal SR; Trahkt I; Spence DW; Poeggeler B; Hardeland R; Cardinali DP
Int J Neurosci; 2009; 119(6):821-46. PubMed ID: 19326288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
